Thursday, July 9, 2026

pharma · Minimal Residual Disease · Pancreatic Ductal Adenocarcinoma · ELTX

Elicio Therapeutics

Elicio Therapeutics trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Boston, USA HQ
47 Employees
Public company Type
ELTX · NYSE Ticker
Company details
Status
Public
HQ
Boston, USA
Employees
47
Programs
2
Drugs
0
Patents
4
Intelligence · Clinical Trials

Elicio Therapeutics clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Elicio Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Elicio Therapeutics trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Elicio Therapeutics.

  1. ELI-002 7P — Phase 2

    Clinical update
  2. ELI-002 2P — Phase 1

    Clinical update

Trial registry

2 studies